SCHEMBL8670836

SCHEMBL8670836

O=C1Cc2cc(CCc3ccc4c(c3)CC(=O)N4)ccc2N1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.59
MAOB P27338 3/20 0.56
PDE3B Q13370 1/20 0.53
PDE3A Q14432 1/20 0.53
HTR1A P08908 5/20 0.52
DRD2 P14416 4/20 0.52
HTR2A P28223 4/20 0.52
ADRA1D P25100 1/20 0.52
ADRA1A P35348 1/20 0.52
ADRA1B P35368 1/20 0.52
PDK2 Q15119 1/20 0.52
EPHX2 P34913 1/20 0.50
SMYD3 Q9H7B4 1/20 0.50
GRIA1 P42261 2/20 0.49
CACNG8 Q8WXS5 2/20 0.49
PGR P06401 1/20 0.49
CYP1A2 P05177 1/20 0.46
CYP11B1 P15538 1/20 0.46
CYP11B2 P19099 1/20 0.46
CMA1 P23946 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL260866 0.90 AHR (0.53) AHRMAOBPDE3BPDE3AHTR1A
SCHEMBL4404868 0.90 AHR (0.57) AHRMAOBPDE3BPDE3AHTR1A
SCHEMBL7349900 0.90 AHR (0.53) AHRMAOBPDE3BPDE3AHTR1A
SCHEMBL15941764 0.90 SMYD3 (0.55) AHRMAOBPDE3BPDE3AHTR1A
SCHEMBL5728887 0.87 AHR (0.54) AHRMAOBPDE3BPDE3AHTR1A
SCHEMBL689189 0.87 AHR (0.50) AHRMAOBPDE3BPDE3AHTR1A
SCHEMBL4551283 0.87 SMYD3 (0.50) AHRMAOBPDE3BPDE3AHTR1A
SCHEMBL20821103 0.85 AHR (0.49) AHRMAOBPDE3BPDE3AHTR1A
SCHEMBL4889909 0.85 AHR (0.53) AHRMAOBPDE3BPDE3AHTR1A
SCHEMBL4551223 0.85 AHR (0.49) AHRMAOBPDE3BPDE3AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed
EP-0686151-A1 SUBSTITUTED CYCLIC CARBONYLS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-12-13 EP disclosed